In Silico Investigation of Pajanelia longifolia (Willd.) K. Schum Bark Extract against NSCLC Targets: Potential Involvement in Apoptotic Pathways

Abstract

Nature provides innumerable answers to human problems, but our knowledge is restricted. The use of medicinal plants to treat health problems dates back to ancient times., It has evolved into contemporary techniques that combine traditional knowledge with modern medicine. Cancer, the biggest cause of mortality worldwide, remains difficult to treat properly. This study focusses on non-small cell lung cancer (NSCLC)., The most common type of lung cancer, accounting for 85-90% of occurrences and associated with factors such as smoking and pollution. Pajanelia longifolia, an Indian traditional medicinal herb, has therapeutic potential and has historically been used to cure a variety of diseases. This study examines the phytochemical elements of P. longifolia bark using metabolite profiling. It evaluates its anti-NSCLC activity using computational methods. The key compounds were identified using liquid chromatography-mass spectrometry (LC-MS), and molecular docking was performed against protein B-Raf and EGFR, both linked to cancer proliferation. The findings emphasise the potential of P. longifolia as a source of bioactive chemicals for cancer therapy. They highlight the need for additional investigation into its medicinal potential, particularly in combination with proven medicines such as irinotecan.

Keywords

Pajanelia longifolia / antioxidant / anticancer / irinotecan / metabolites profiling

References

[1] Nath R.; Saha P.; Nath D.; et al. Plant Essential Oils and Anticancer Properties:An Update. In Medicinal Plants; CRC Press: Boca Raton, FL, USA, 2019; pp. 189-203

[2] Roy A.; Ahuja S.; Bharadvaja N. A review on medicinal plants against cancer. J. Plant Sci. Agric. Res. 2017, 2, 8.

[3] McGuire S. World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press 2015. Adv. Nutr. 2016, 7, 418-419

[4] Nath R.; Singha S.; Nath D.; et al. Phytochemicals from Allium tuberosum Rottler ex Spreng show potent inhibitory activity against B-Raf, EGFR, K-Ras, and PI3K of non-small cell lung cancer targets.Appl. Sci. 2022, 12, 11749.

[5] Leiter A.; Veluswamy R.R.; Wisnivesky J.P. The global burden of lung cancer: Current status and future trends. Nat. Rev. Clin. Oncol. 2023, 20, 624-639.

[6] Choudhury P.R.; Choudhury M.D.; Ningthoujam S.S.; et al. Ethnomedicinal plants used by traditional healers of North Tripura district, Tripura, North East India. J. Ethnopharmacol. 2015, 166, 135-148.

[7] Saha P.; Talukdar A.D.; Choudhury M.D. Antioxidant Potential Profile of Pajanelia longifolia (WILLD.) K. SCHUMAN; Potential New Sources of Natural Antioxidant. Asian J. Pharm. Clin. Res. 2017, 10, 184-188.

[8] Zainab A.; Bhat R.; Acharya S.; et al. Studies on antioxidant and antimicrobial activities of Pajanelia longifolia (Willd.) Schumann. Obes. Res. J. 2013, 2013, 756484.

[9] Chin Y.W.; Balunas M.J.; Chai H.B.; et al. Drug discovery from natural sources. AAPS J. 2006, 8, E239-E253.

[10] Datta S.; Choudhury M.D. Oxidative stress reducing and liver protective efficacy of ethyl acetate fraction isolated from Pajanelia longifolia (willd) K. Schuman. Lipids 2017, 1, 2.

[11] Datta S.; Choudhury S.; Choudhury M.D. Hepatoprotective Activity of Bark Extracts of Pajanelia longifolia (Willd.) K. Schuman against CCl 4 Induced Hepatic Damage in Mice. Drug Invent. Today 2012, 4, 537.

[12] Trusheva B.; Trunkova D.; Bankova V. Different extraction methods of biologically active components from propolis: A preliminary study. Chem. Cent. J. 2007, 1, 1-4.

[13] Singleton V.L.; Orthofer R.; Lamuela-Raventós R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. In Methods in Enzymology; Academic Press: Cambridge, MA, USA, 1999; Volume 299, pp. 152-178.

[14] Arvouet-Grand A.; Vennat B.; Pourrat A.; et al. Standardization of propolis extract and identification of principal constituents.J. Pharm. Belg. 1994, 49, 462-468.

[15] Kumarasamy Y.; Byres M.; Cox P.J.; et al. Screening seeds of some Scottish plants for free radical scavenging activity. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2007, 21, 615-621.

[16] Huang Y.C.; Sung M.Y.; Lin T.K.; et al. Chinese herbal medicine compound of flavonoids adjunctive treatment for oral cancer. J. Formos. Med. Assoc. 2024, 123, 830-836.

[17] Sparreboom A.; Zamboni W.C. Topoisomerase I-targeting drugs. In Cancer Chemotherapy and Biotherapy; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006; pp. 371-413.

[18] Lipinski C.A. Avoiding investment in doomed drugs. Curr Drug Discov 2001, 1, 17-19.

[19] Brenk R.; Schipani A.; James D.; et al. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem Chem. Enabling Drug Discov. 2008, 3, 435-444.

[20] Nath R.; Das C.; Kityania S.; et al. Natural flavonoids in the prevention and treatment of lung cancer: A pharmacological aspect. Comb. Chem. High Throughput Screen. 2023, 26, 863-879.